Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cory Abate-Shen"'
Autor:
Alessandro Vasciaveo, Juan Martín Arriaga, Francisca Nunes de Almeida, Min Zou, Eugene F. Douglass, Florencia Picech, Maho Shibata, Antonio Rodriguez-Calero, Simone de Brot, Antonina Mitrofanova, Chee Wai Chua, Charles Karan, Ronald Realubit, Sergey Pampou, Jaime Y. Kim, Stephanie N. Afari, Timur Mukhammadov, Luca Zanella, Eva Corey, Mariano J. Alvarez, Mark A. Rubin, Michael M. Shen, Andrea Califano, Cory Abate-Shen
Publikováno v:
Cancer discovery.
Prioritizing treatments for individual patients with cancer remains challenging, and performing coclinical studies using patient-derived models in real time is often unfeasible. To circumvent these challenges, we introduce OncoLoop, a precision medic
Autor:
Karen E. Knudsen, Cory Abate-Shen, Charles Swanton, Gordon B. Mills, Adriana Albini, David A. Tuveson, René Bernards, Lillian L. Siu, Carl H. June, Elaine R. Mardis, Margaret Foti, Philip D. Greenberg, Antoni Ribas, Keith T. Flaherty, William N. Hait, Martine F. Roussel, Martine Piccart, Elizabeth M. Jaffee, Edison T. Liu, Marcia Cruz-Correa
Publikováno v:
Cancer discovery. 10(6)
On March 30, 2020, the AACR Board of Directors provided a letter to the U.S. Congressional leadership on behalf of its members in response to the COVID-19 public health emergency.
Autor:
Cory Abate-Shen, Lukas E. Dow, Amanda Kulick, Corina Amor, Nelson R. Salgado, Marcus Ruscetti, Teng Han, Philip A. Watson, Kaloyan M. Tsanov, Zhen Cao, Leah Zamechek, Yu-Jui Ho, Judith Feucht, Charles L. Sawyers, Francisco M. Barriga, Sha Tian, Min Zou, Wassim Abida, John E. Wilkinson, Elisa de Stanchina, Francisco J. Sánchez-Rivera, Scott W. Lowe, Josef Leibold, Katarzyna Rybczyk, Timour Baslan
Publikováno v:
Cancer Discov
To study genetic factors influencing the progression and therapeutic responses of advanced prostate cancer, we developed a fast and flexible system that introduces genetic alterations relevant to human disease directly into the prostate glands of mic
Autor:
Cory Abate-Shen, Clémentine Le Magnen, Min Zou, Antonina Mitrofanova, Andrea Califano, Nicolas Floc'h, Yanping Sun, Mark A. Rubin, Elahe A. Mostaghel, Sheida Hayati, Michael M. Shen, Roxanne Toivanen, Daniel Chester
Publikováno v:
Cancer discovery. 7(7)
Current treatments for castration-resistant prostate cancer (CRPC) that target androgen receptor (AR) signaling improve patient survival, yet ultimately fail. Here, we provide novel insights into treatment response for the antiandrogen abiraterone by